Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by PTBaileyon Mar 23, 2022 4:09pm
167 Views
Post# 34539170

From Claritas Investors FB page

From Claritas Investors FB pageDrew:

Spoke with Bob yesterday and the questions are less in number and relegated to clarifying words and cut off sentences type of thing so we have to be near the end.
From what I understand we have already gotten a cohort ready to start so soon as we get the go ahead we're off.
Warrants, well, expect the worst and hope for the best. Both are an even possibility in my mind.
Oh, a note. The rumor and slur going around that Bob doesn't give care about warrant holders is bogus. He wants to have those exercised more than we do as it would virtually stuff $8 million into the Claritas kitty with a paltry 5% dilution vs the high dilution vehicles we presently have at our disposal.
He has been, and is doing everything he can to get these in the money.

<< Previous
Bullboard Posts
Next >>